Terms: = Prostate cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51
214 results:
1. Medication-based Comorbidity Measures and prostate cancer Treatment Selection.
Tiruye T; O'Callaghan M; FitzGerald LM; Moretti K; Jay A; Higgs B; Kichenadasse G; Caughey G; Roder D; Beckmann K
Clin Genitourin Cancer; 2024 Apr; 22(2):599-609.e2. PubMed ID: 38369388
[TBL] [Abstract] [Full Text] [Related]
2. Food additive emulsifiers and cancer risk: Results from the French prospective NutriNet-Santé cohort.
Sellem L; Srour B; Javaux G; Chazelas E; Chassaing B; Viennois E; Debras C; Druesne-Pecollo N; Esseddik Y; Szabo de Edelenyi F; Arnault N; Agaësse C; De Sa A; Lutchia R; Huybrechts I; Scalbert A; Pierre F; Coumoul X; Julia C; Kesse-Guyot E; Allès B; Galan P; Hercberg S; Deschasaux-Tanguy M; Touvier M
PLoS Med; 2024 Feb; 21(2):e1004338. PubMed ID: 38349899
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptional Inflammatory Signature in Healthy Donors and Different Radiotherapy cancer Patients.
O'Brien G; Kamuda M; Cruz-Garcia L; Polozova M; Tichy A; Markova M; Sirak I; Zahradnicek O; Widłak P; Ponge L; Polanska J; Badie C
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256152
[TBL] [Abstract] [Full Text] [Related]
4. Safer and More Convenient Modern Curative Radiotherapy for Patients With Early prostate cancer.
Reinikainen P; Lehtinen I; Luukkaala T; Kellokumpu-Lehtinen PL
Anticancer Res; 2024 Jan; 44(1):139-150. PubMed ID: 38159980
[TBL] [Abstract] [Full Text] [Related]
5. Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [
Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):896-906. PubMed ID: 37889299
[TBL] [Abstract] [Full Text] [Related]
6. S-adenosylmethionine treatment affects histone methylation in prostate cancer cells.
Mathes A; Duman MB; Neumann A; Dobreva G; Schmidt T
Gene; 2024 Jan; 893():147915. PubMed ID: 37866662
[TBL] [Abstract] [Full Text] [Related]
7. Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study.
Huang HP; Chen CH; Chang KH; Lee MS; Lee CF; Chao YH; Lu SY; Wu TF; Liang ST; Lin CY; Lin YC; Liu SP; Lu YC; Shun CT; Huang WJ; Lin TP; Ku MH; Chung HJ; Chang YH; Liao CH; Yu CC; Chung SD; Tsai YC; Wu CC; Chen KC; Ho CH; Hsiao PW; Pu YS
J Transl Med; 2023 Oct; 21(1):714. PubMed ID: 37821919
[TBL] [Abstract] [Full Text] [Related]
8. Effect of Socioeconomic Disparities on Suicide Risk in Patients With prostate cancer During 2005 to 2020: A Population Study.
Jia YJ; Hu FH; Tang W; Zhang WQ; Ge MW; Shen LT; Hu SQ; Shen WQ; Chen HL
Clin Genitourin Cancer; 2024 Apr; 22(2):84-91.e7. PubMed ID: 37758561
[TBL] [Abstract] [Full Text] [Related]
9. Pretest Video Education Versus Genetic Counseling for Patients With prostate cancer: ProGen, A Multisite Randomized Controlled Trial.
Rana HQ; Stopfer JE; Weitz M; Kipnis L; Koeller DR; Culver S; Mercado J; Gelman RS; Underhill-Blazey M; McGregor BA; Sweeney CJ; Petrucelli N; Kokenakes C; Pirzadeh-Miller S; Reys B; Frazier A; Knechtl A; Fateh S; Vatnick DR; Silver R; Kilbridge KE; Pomerantz MM; Wei XX; Choudhury AD; Sonpavde GP; Kozyreva O; Lathan C; Horton C; Dolinsky JS; Heath EI; Ross TS; Courtney KD; Garber JE; Taplin ME
JCO Oncol Pract; 2023 Nov; 19(11):1069-1079. PubMed ID: 37733980
[TBL] [Abstract] [Full Text] [Related]
10. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of prostate cancer After Radical prostatectomy.
Merriman KM; Harmon SA; Belue MJ; Yilmaz EC; Blake Z; Lay NS; Phelps TE; Merino MJ; Parnes HL; Law YM; Gurram S; Wood BJ; Choyke PL; Pinto PA; Turkbey B
AJR Am J Roentgenol; 2023 Dec; 221(6):773-787. PubMed ID: 37404084
[No Abstract] [Full Text] [Related]
12. prostate cancer detection and segmentation on MRI using non-local mask R-CNN with histopathological ground truth.
Dai Z; Jambor I; Taimen P; Pantelic M; Elshaikh M; Dabaja A; Rogers C; Ettala O; Boström PJ; Aronen HJ; Merisaari H; Wen N
Med Phys; 2023 Dec; 50(12):7748-7763. PubMed ID: 37358061
[TBL] [Abstract] [Full Text] [Related]
13. Comparing Risk for Second Primary cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for prostate cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract] [Full Text] [Related]
14. Bridging the experience gap in prostate multiparametric magnetic resonance imaging using artificial intelligence: A prospective multi-reader comparison study on inter-reader agreement in PI-RADS v2.1, image quality and reporting time between novice and expert readers.
Forookhi A; Laschena L; Pecoraro M; Borrelli A; Massaro M; Dehghanpour A; Cipollari S; Catalano C; Panebianco V
Eur J Radiol; 2023 Apr; 161():110749. PubMed ID: 36812699
[TBL] [Abstract] [Full Text] [Related]
15. Post-transplant diabetes mellitus and renal cell cancer after renal transplantation.
Porrini E; Montero N; Díaz JM; Lauzurrica R; Rodríguez JO; Torres IS; Moreso F; Cruzado JM; Ruiz RB; Vilaró MI; Lima MXM; Ramchand SK; Ruiz JC; Gainza de Los Rios F; Alvarez CR; Guindo MDCG; Macías M; Vela DB; Osuna A; Bayés-Genís B; Sanchez CA; Ruiz MDC; Rodríguez AER; Rollán RD; Rinne FG; Sosa AJ; Mallén PD; Rinne AG; Miranda DM; Torres A
Nephrol Dial Transplant; 2023 May; 38(6):1552-1559. PubMed ID: 36323457
[TBL] [Abstract] [Full Text] [Related]
16. Cost-effectiveness analysis of primary treatments for localised prostate cancer: A population-based Markov analysis using real-world evidence.
Weng X; Zhong L; Xiang P; Li Y; Paciorek A; Dong L; Broering J; Carroll PR; Sanda M; Wilson L
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13740. PubMed ID: 36239065
[TBL] [Abstract] [Full Text] [Related]
17. Effects of acute exercise training on tumor outcomes in men with localized prostate cancer: A randomized controlled trial.
Djurhuus SS; Schauer T; Simonsen C; Toft BG; Jensen ARD; Erler JT; Røder MA; Hojman P; Brasso K; Christensen JF
Physiol Rep; 2022 Oct; 10(19):e15408. PubMed ID: 36199257
[TBL] [Abstract] [Full Text] [Related]
18. Health-related Quality of Life of Patients Treated With Different Fractionation Schedules for Early prostate cancer Compared to the Age-standardized General Male Population.
Reinikainen P; Lehtonen M; Lehtinen I; Luukkaala T; Sintonen H; Kellokumpu-Lehtinen PL
Clin Genitourin Cancer; 2023 Feb; 21(1):146-154. PubMed ID: 36038484
[TBL] [Abstract] [Full Text] [Related]
19. Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With cancer.
Taparra K; Qu V; Pollom E
JAMA Netw Open; 2022 Aug; 5(8):e2226327. PubMed ID: 35960520
[TBL] [Abstract] [Full Text] [Related]
20. Mapping cancer in Africa: A Comprehensive and Comparable Characterization of 34 cancer Types Using Estimates From GLOBOCAN 2020.
Sharma R; Aashima ; Nanda M; Fronterre C; Sewagudde P; Ssentongo AE; Yenney K; Arhin ND; Oh J; Amponsah-Manu F; Ssentongo P
Front Public Health; 2022; 10():839835. PubMed ID: 35548083
[TBL] [Abstract] [Full Text] [Related]
[Next]
